- 4.9Impact Factor
- 9.0CiteScore
- 21 daysTime to First Decision
Molecular Insights into Cardiomyopathy
This special issue belongs to the section “Molecular Pathology, Diagnostics, and Therapeutics“.
Special Issue Information
Dear Colleagues,
Cardiomyopathies comprise a heterogeneous group of heart muscle disorders with diverse etiologies, including genetic, metabolic, inflammatory, and hormonal reasons. For many years, therapeutic strategies were largely limited to heart failure therapy, as no targeted therapies were yet available. However, recent advances in molecular research have transformed this paradigm. Studies elucidating the molecular and cellular pathways driving cardiomyopathy have provided the foundation for mechanism-based therapies. Notable examples are the advent of transthyretin stabilizers such as tafamidis in cardiac amyloidosis and myosin modulators like mavacamten in hypertrophic cardiomyopathy. These therapeutic breakthroughs demonstrate how insights into molecular pathophysiology can directly translate into disease-specific treatments that improve morbidity, mortality, and quality of life for affected patients.
This Special Issue of the International Journal of Molecular Sciences is dedicated to advancing our understanding of the molecular mechanisms underlying cardiomyopathies. It brings together original research articles and comprehensive reviews addressing genetic, biochemical, and cellular aspects of disease development and progression, as well as translational studies exploring novel therapeutic targets. By highlighting the intersection of basic molecular science and clinical application, this collection aims to provide a platform for innovative concepts that may pave the way for new disease-modifying therapies.
Dr. Selina Hein
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiomyopathy
- inflammation
- molecular mechanisms
- targeted therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

